Phase D of reaccumulation with key resistance level just above (likely to slow down upward move). All signs still point up after overcoming that barrier.
Glad to see you tracking Novavax. The next two months will be interesting for them. They will be the last of the vaccines but quite possibly the best. If other vaccines can make it to market successfully this may lower the temp on NVAX. Any struggles will be to the benefit of NVAX. They have bought into a very extensive manufacturing program that is global.
QualQuantTrade
⋅
@WolfTraderJim, yes, their vaccine is based on validated methods and, as far as I know, the only one of the top candidates that is. While it seems that the other technologies are promising, I have confidence that the NVAX vaccine will deliver.
Chartguru1
⋅
@QualQuantTrade, funny the weekly chart shows promising MACD crossover within next 4 weeks. Great job on the chart !
PrimaTrader
⋅
Is there any updated analysis for NVAX? Also, do you have any PFE analysis?
QualQuantTrade
⋅
@PrimaTrader, this analysis still applies to current price action on NVAX. Looks like it's playing around that breakout level. Also looks like a pennant forming on the chart (accompanied by decreasing volume which is good). I see this as a bullish chart with breakup soon (all depends on news).